{{Rsnum
|rsid=9333649
|Chromosome=7
|Orientation=minus
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene=KCNH2
|position=150951679
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=KCNH2
}}{{omim
|id=152427
|rsnum=9333649
|variant=0010
}}

{{ClinVar
|rsid=9333649
|Reversed=1
|FwdREF=G
|FwdALT=A,C,T
|REF=C
|ALT=A,G,T
|RSPOS=150648767
|CHROM=7
|dbSNPBuildID=119
|SSR=0
|SAO=1
|VP=0x050168000000000102110104
|GENEINFO=KCNH2:3757
|GENE_NAME=KCNH2
|GENE_ID=3757
|WGT=0
|VC=SNV
|CLNALLE=1; 2; 3
|CLNHGVS=NC_000007.13:g.150648767C>A; NC_000007.13:g.150648767C>G; NC_000007.13:g.150648767C>T
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=152427.0010
|CLNSIG=5
|CLNCUI=C1835325
|CLNDBN=not provided; Long QT syndrome 2
|Disease=not provided; Long QT syndrome 2
|CLNACC=RCV000057961.1; RCV000015510.20; RCV000057960.1; RCV000057959.1
|Tags=RV;PM;PMC;SLO;GNO;OTHERKG;LSD;OM;NOV
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet
|CLNDSDBID=NBK1129:C3150943:613688:101016
}}

{{PMID|19214780|OA=1
}} In silico investigations on functional and haplotype tag SNPs associated with congenital long QT syndromes (LQTSs).

{{PMID|9693036}} Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1.

{{PMID|10973849}} Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

{{PMID|20931}} Calorimetric and equilibrium binding studies of the interaction of substrates with glutamine synthetase of Escherichia coli.

{{PMID|10220146}} High-throughput single-strand conformation polymorphism analysis by automated capillary electrophoresis: robust multiplex analysis and pattern-based identification of allelic variants.

{{PMID|10735633}} Long QT syndrome with a high mortality rate caused by a novel G572R missense mutation in KCNH2.

{{PMID|10973849}} Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

{{PMID|11468227}} Screening for mutations and polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac HERG/MiRP1 ion channel: implications for acquired and congenital long Q-T syndrome.

{{PMID|11668638}} Automated mutation screening using dideoxy fingerprinting and capillary array electrophoresis.

{{PMID|18752}} Effect of apomorphine on the antinociceptive activity of morphine.

{{PMID|15176425}} Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland.

{{PMID|15840476}} Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

{{PMID|16432067}} Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.

{{PMID|16831322}} [Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].

{{PMID|17905336}} Long QT and Brugada syndrome gene mutations in New Zealand.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}